M. E. Harper

5.2k citations

71 papers · 4.4k · 1 hit paper · h-index 28

Impact in

Oncology top 1%
- HER2/EGFR in Cancer Research
Pulmonary and Respiratory Medicine top 1%
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
- Prostate Cancer Diagnosis and Treatment

Papers in

Pulmonary and Respiratory Medicine 30
- Prostate Cancer Treatment and Research 26
- Prostate Cancer Diagnosis and Treatment 11
Endocrinology, Diabetes and Metabolism 26
- Hormonal and reproductive studies 23

Co-authors: Julia M.W. Gee (16 shared papers)Robert I. Nicholson (16 shared papers)K. Griffiths (40 shared papers)W.B. Peeling (17 shared papers)Denise Barrow (13 shared papers)Iain R. Hutcheson (8 shared papers)Janice M. Knowlden (8 shared papers)Lindy Goddard (13 shared papers)
Journals: The Prostate (13 papers)Journal of Endocrinology (6 papers)International Journal of Cancer (4 papers)The Journal of Urology (4 papers)European Journal of Cancer (3 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

M. E. Harper

68 papers receiving 4.2k citations

M. E. Harper's Hit Papers

align trajectories log scale

EGFR and cancer prognosis 2001 · 1.8k citations

Peers

Countries citing papers authored by M. E. Harper

Since Specialization

Citations

This map shows the geographic impact of M. E. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Harper more than expected).

Fields of papers citing papers by M. E. Harper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. E. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Harper. The network helps show where M. E. Harper may publish in the future.

Co-authors

The 25 scholars most cited alongside M. E. Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. E. Harper Line = papers co-authored together M. E. Harper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	EGFR and cancer prognosis European Journal of Cancer ·Robert I. Nicholson, Julia M.W. Gee, M. E. Harper Hit paper breakdown →	2001	1773
2	Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells Endocrinology ·Janice M. Knowlden, Iain R. Hutcheson, Helen E. Jones, Tracie‐Ann Madden, Julia M.W. Gee, M. E. Harper, Denise Barrow, Alan E. Wakeling, Robert I. Nicholson	2003	451
3	STEROIDS OF ADRENAL ORIGIN METABOLIZED BY HUMAN PROSTATIC TISSUE BOTH IN VIVO AND IN VITRO Journal of Endocrinology ·M. E. Harper, Adrian W. Pike, W.B. Peeling, K. Griffiths	1974	178
4	The Antiepidermal Growth Factor Receptor Agent Gefitinib (ZD1839/Iressa) Improves Antihormone Response and Prevents Development of Resistance in Breast Cancer in Vitro Endocrinology ·Julia M.W. Gee, M. E. Harper, Iain R. Hutcheson, T. Madden, Denise Barrow, Janice M. Knowlden, R A McClelland, Nicola Jordan, A. E. Wakeling, Robert I. Nicholson	2003	143
5	Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer. Endocrine Related Cancer ·R.I. Nicholson, Iain R. Hutcheson, M. E. Harper, J M Knowlden, Denise Barrow, R A McClelland, Helen E. Jones, A. E. Wakeling, Julia M.W. Gee	2001	137
6	Nonendocrine Pathways and Endocrine Resistance Clinical Cancer Research ·Robert I. Nicholson, Iain R. Hutcheson, Janice M. Knowlden, Helen Jones, M. E. Harper, Nicola Jordan, (unknown), Denise Barrow, Julia M.W. Gee	2004	102
7	PLASMA STEROID AND PROTEIN HORMONE CONCENTRATIONS IN PATIENTS WITH PROSTATIC CARCINOMA, BEFORE AND DURING OESTROGEN THERAPY European Journal of Endocrinology ·M. E. Harper, W.B. Peeling, Teresa Cowley, Brian G. Brownsey, M. E. Phillips, G. V. Groom, D.R. Fahmy, K. Griffiths	1976	95
8	Carcinoma of the prostate: Relationship of pretreatment hormone levels to survival European Journal of Cancer and Clinical Oncology ·M. E. Harper, C. G. PIERREPOINT, K. Griffiths	1984	76
9	Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis The Prostate ·B. A. J. Evans, M. E. Harper, C. Daniells, C.E. Watts, S. S. Matenhelia, J. Green, K. Griffiths	1996	75
10	Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters The Prostate ·M. E. Harper, E Glynne-Jones, Lindy Goddard, Douglas W. Wilson, K. Griffiths, I.G. Conn, S. S. Matenhelia, W.B. Peeling	1992	66
11	An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors The Prostate ·M. E. Harper, Lindy Goddard, E Glynne-Jones, Douglas W. Wilson, M. Price‐Thomas, W.B. Peeling, K. Griffiths	1993	65
12	Comparative analysis of mrna and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue Human Pathology ·E Glynne-Jones, Lindy Goddard, M. E. Harper	1996	59
13	Modulation of Epidermal Growth Factor Receptor in Endocrine‐Resistant, Estrogen‐Receptor‐Positive Breast Cancer Annals of the New York Academy of Sciences ·Robert I. Nicholson, Iain R. Hutcheson, M. E. Harper, Janice M. Knowlden, Denise Barrow, R A McClelland, Helen E. Jones, A. E. Wakeling, Julia M.W. Gee	2002	54
14	Expression of androgen receptor and growth factors in premalignant lesions of the prostate The Journal of Pathology ·M. E. Harper, Eve Glynne‐Jones, Lindy Goddard, Phillip Mathews, Robert I. Nicholson	1998	53
15	TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence International Journal of Cancer ·E Glynne-Jones, M. E. Harper, Liam T. Seery, Rhianedd James, Ian E. Anglin, Helen Morgan, KM Taylor, Julia M.W. Gee, Robert I. Nicholson	2001	51
16	Pathological and clinical associations of Ki‐67 defined growth fractions in human prostatic carcinoma The Prostate ·M. E. Harper, Lindy Goddard, Douglas W. Wilson, K. Griffiths, I.G. Conn, S.S. Matanhelia, W.B. Peeling	1992	48
17	Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour–stroma interactions Endocrine Related Cancer ·Stephen Hiscox, Nicola Jordan, Wen G. Jiang, M. E. Harper, Richard A. McClelland, Christopher R. Smith, Robert I. Nicholson	2006	47
18	Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies The Journal of Steroid Biochemistry and Molecular Biology ·R.I. Nicholson, Iain R. Hutcheson, D. Britton, Janice M. Knowlden, Helen Jones, M. E. Harper, Stephen Hiscox, Denise Barrow, Julia M.W. Gee	2005	47
19	New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145 International Journal of Cancer ·Helen Jones, Carol M. Dutkowski, Denise Barrow, M. E. Harper, Alan E. Wakeling, Robert I. Nicholson	1997	42
20	THE EFFECT OF CERTAIN STILBOESTROL ANALOGUES ON PLASMA PROLACTIN AND TESTOSTERONE IN THE RAT Journal of Endocrinology ·V. Danutra, M. E. Harper, A. R. BOYNS, E.N. Cole, Brian G. Brownsey, K. Griffiths	1973	41

About M. E. Harper

M. E. Harper is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Molecular Biology, Oncology and Genetics, having authored 71 papers that have together received 4.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (26 papers), Hormonal and reproductive studies (23 papers), Estrogen and related hormone effects (11 papers), Prostate Cancer Diagnosis and Treatment (11 papers), HER2/EGFR in Cancer Research (10 papers), Urologic and reproductive health conditions (6 papers), Pharmacological Effects and Assays (5 papers) and Urinary Bladder and Prostate Research (4 papers). The work is most often cited by research in Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.4k citations), Endocrinology, Diabetes and Metabolism (668 citations), Cancer Research (490 citations) and Genetics (676 citations). M. E. Harper has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Julia M.W. Gee, Robert I. Nicholson, K. Griffiths, W.B. Peeling, Denise Barrow, Iain R. Hutcheson, Janice M. Knowlden, Lindy Goddard, Helen E. Jones and C. G. PIERREPOINT. Their work appears in journals such as The Prostate, Journal of Endocrinology, International Journal of Cancer, The Journal of Urology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

M. E. Harper

Impact in

Papers in i

In The Last Decade

M. E. Harper

M. E. Harper's Hit Papers

Peers

Countries citing papers authored by M. E. Harper

Fields of papers citing papers by M. E. Harper

All Works

About M. E. Harper

Explore authors with similar magnitude of impact

Papers in